2376
S. Fukuzawa et al. / Tetrahedron Letters 50 (2009) 2374–2376
9202–9211; (c) Hayakawa, M.; Kaizawa, H.; Kawaguchi, K.; Ishikawa, N.;
O2, X-
'Cu'
Ar-H, base
base·HX
Koizumi, T.; Ohishi, T.; Yamano, M.; Okada, M.; Ohta, M.; Tsukamoto, S.;
Raynaud, F. I.; Waterfield, M. D.; Parker, P.; Workman, P. Bioorg. Med. Chem.
2007, 15, 403–412; (d) Gu, Y. G.; Weitzberg, M.; Clark, R. K.; Xu, X.; Li, Q.;
Zhang, T.; Hansen, T. M.; Liu, G.; Xin, Z.; Wang, X.; Wang, R.; McNally, T.; Camp,
H.; Beutel, B. A.; Sham, H. L. J. Med. Chem. 2006, 49, 3770–3773; (e) Sheldrake,
P. W.; Matteicci, M.; McDonald, E. Synlett 2006, 460–462; (f) Tandon, V. K.;
Yadav, D. B.; Singh, R. V.; Chaturvedi, A. K.; Shukla, P. K. Bioorg. Med. Chem. Lett.
2005, 15, 5324–5328; (g) Kazimierczuk, Z.; Andrzejewska, M.; Kaustova, J.;
Klimešova, V. Eur. J. Med. Chem. 2005, 40, 203–208; (h) Llauger, L.; He, H.; Kim,
J.; Aguirre, J.; Rosen, N.; Peters, U.; Davies, P.; Chiosis, G. J. Med. Chem. 2005, 48,
2892–2905; (i) Martino, G. D.; Regina, G. L.; Coluccia, A.; Edler, M. C.; Barbera,
M. C.; Brancale, A.; Wilcox, E.; Hamel, E.; Artico, M.; Silvestri, R. J. Med. Chem.
2004, 47, 6120–6123; (j) Meng, C. Q.; Somers, P. K.; Hoong, L. K.; Zheng, X. S.;
Ye, Z.; Worsencroft, K. J.; Simpson, J. E.; Hotema, M. R.; Weingarten, M. D.;
MacDonald, M. L.; Hill, R. R.; Marino, E. M.; Suen, K.-L.; Luchoomum, J.; Kunsch,
C.; Landers, L. K.; Stefanopoulos, D.; Howard, R. B.; Sundell, C. L.; Saxena, U.;
Wasserman, M. A.; Sikorski, J. A. J. Med. Chem. 2004, 47, 6420–6432; (k) Dumas,
J.; Brittelli, D.; Chen, J.; Dixon, B.; Hatoum-Mokdad, H.; König, G.; Sibley, R.;
Witowsky, J.; Wong, S. Bioorg. Med. Chem. Lett. 1999, 9, 2531–2536.
12. Typical experimental procedure: Under oxygen (balloon), 2a (55 mg, 0.25 mmol),
CuI (9.5 mg, 0.05 mmol), 2,20-bipyridine (7.8 mg, 0.05 mmol), and Cs2CO3
(326 mg, 1.0 mmol) were placed in a Schlenk tube containing a stirring bar, and
a DMF solution (3.0 mL) of 1a (71.5 mg, 0.6 mmol) was then added to the
Schlenk tube, and the resulting mixture was heated at 80 °C for 2 h. Twenty
milliliters of water were then added, and the mixture was then extracted with
ethyl acetate (10 mL ꢀ 3). The combined organic phases were washed with
brine, dried over MgSO4, and filtered. GC/MS analysis of the solution showed
the presence of 2-(phenylthio)benzoxazole (3aa) and yield was determined
using biphenyl as the internal standard. Evaporation of the solvent left a
residue, which was subjected to PTLC (silica gel, 8:1 hexane:ethyl acetate as
eluent) to give the pure 3aa.
CuX
ArSPh
Ar-Cu
PhSSPh
ArSPh
ArCuSPh
base·HX
Ar-H
PhSCu
O2, X-
PhSCuX
base
Scheme 1. Plausible catalytic cycle of the direct thiolation.
The scope and limitation of the substrate with respect to azoles
have also been demonstrated.
References and notes
1. For reviews: (a) Hartwig, J. F. Acc. Chem. Res. 2008, 41, 1534–1544; (b) Kunz, K.;
Scholz, U.; Ganzer, D. Synlett 2003, 2428–2439; (c) Ley, S. V.; Thomas, A. W.
Angew. Chem., Int. Ed. 2003, 42, 5400–5449; (d) Kondo, T.; Mitsudo, T. Chem.
Rev. 2000, 100, 3205–3220.
2. (a) Lee, J.-Y.; Lee, P. H. J. Org. Chem. 2008, 73, 7413–7416; (b) Fernández-
Rodríguez, M. A.; Hartwig, J. F. J. Org. Chem. ASAP.; (c) Fernández-Rodríguez, M.
A.; Shen, Q.; Hartwig, J. F. J. Am. Chem. Soc. 2006, 128, 2180; (d) Cai, L.; Cuevas,
J.; Peng, Y.-Y.; Pike, V. W. Tetrahedron Lett. 2006, 47, 4449–4452; (e) Murata,
M.; Buchwald, S. L. Tetrahedron 2004, 60, 7397–7403; (f) Schopfer, U.;
Schlapbach, A. Tetrahedron 2001, 57, 3069–3073; (g) Migita, T.; Shimizu, T.;
Asami, Y.; Shiobara, J.; Kato, Y.; Kosugi, M. Bull. Chem. Soc. Jpn. 1980, 53, 1385–
1389; (h) Kosugi, M.; Shimizu, T.; Migita, T. Chem. Lett. 1978, 13–14; (i) Haslam,
E. Shikimic Acid Metabolism and Metabolites; John Wiley & Sons: New York,
1993.
Compound 3aa: Colorless oil. 1H NMR (CDCl3, 300 MHz) d 7.21–7.30 (m, 2H),
7.40–7.47 (m, 4H), 7.59–7.62 (m, 1H), 7.69–7.72 (m, 2H); 13C NMR (CDCl3) d
110.0 (CH), 119.0 (CH), 124.2 (CH), 124.3 (CH), 127.1 (C) 129.6 (CH), 129.8
(CH), 134.4 (CH), 141.9 (C), 151.8 (C), 163.3 (C). ESI HRMS calcd for C13H9NOS
[M + H] 228.0483, found 228.0481. EI MS m/z = 227.
Compound 3ab: Colorless oil. 1H NMR (CDCl3, 300 MHz) d 3.84 (s, 3H), 6.98 (d,
2H, J = 8.6 Hz), 7.18–7.28 (m, 2H), 7.36–7.41 (m, 1H), 7.57–7.59 (m, 1H), 7.62
(d, 2H, J = 8.7 Hz); 13C NMR (CDCl3) d 55.4 (CH3), 109.9 (CH), 115.2 (CH), 117.0
(C), 118.9 (CH), 124.0 (CH), 124.2 (CH), 136.7 (CH), 142.0 (C), 151.8 (C), 161.1
(C), 164.4 (C). ESI HRMS calcd for C14H11NO2S [M + H] 258.0589, found
258.0585. EI MS m/z = 257.
3. (a) Jammi, S.; Barua, P.; Rout, L.; Saha, P.; Punniyamurthy, T. Tetrahedron Lett.
2008, 49, 1484–1487; (b) Zhang, Y.; Ngeow, K. C.; Ying, J. Y. Org. Lett. 2007, 9,
3495–3498; (c) Takagi, K. Chem. Lett. 1987, 2221–2224.
Compound 3ac: Colorless oil. 1H NMR (CDCl3, 300 MHz) d 2.41 (s, 3H), 7.20–
7.26 (m, 2H), 7.27 (d, 2H, J = 8.0 Hz), 7.39–7.42 (m, 1H), 7.59 (d, 2H, J = 8.0 Hz),
7.60 (m, 1H); 13C NMR (CDCl3) d 21.4 (CH3), 110.0 (CH), 119.0 (CH), 123.3 (C),
124.1 (CH), 124.3 (CH), 130.5 (CH), 134.7 (CH), 140.4 (C), 142.0 (C), 151.9 (C),
164.0 (C). ESI HRMS calcd for C14H11NOS [M + H] 242.0640, found 242.0672. EI
MS m/z = 241.
4. (a) Prasad, D. J. C.; Naidu, A. B.; Sekar, G. Tetrahedron Lett., in press.; (b) Herrero,
M. T.; SanMartin, R.; Domínguez, E. Tetrahedron 2009, 65, 1500–1503; (c) Xu,
H.-J.; Zhao, X.-Y.; Deng, J.; Fu, Y.; Feng, Y.-S. Tetrahedron Lett. 2009, 50, 434–
437; (d) She, J.; Jiang, Z.; Wang, Y. Tetrahedron Lett. 2009, 50, 593–596; (e)
Ranu, C. B.; Saha, A.; Jana, R. Adv. Synth. Catal. 2007, 349, 2690–2696; (f)
Buranaprasertsuk, P.; Chang, J. W. W.; Chavasiri, W.; Chan, P. W. H. Tetrahedron
Lett. 2008, 49, 2023–2025; (g) Rout, L.; Saha, P.; Jammi, S.; Punniyamurthy, T.
Eur. J. Org. Chem. 2008, 640; (h) Xu, H.-J.; Zhao, X.-Y.; Fu, Y.; Feng, Y.-S. Synlett
2008, 3063–3067; (i) Sperotto, E.; van Klink, G. P. M.; de Vries, J. G.; van Koten,
G. J. Org. Chem. 2008, 73, 5625–5628; (j) Lv, X.; Bao, W. J. Org. Chem. 2007, 72,
3863–3867; (k) Verma, A. K.; Singh, J.; Chaudhary, R. Tetrahedron Lett. 2007, 48,
7199–7202; (l) Rout, L.; Sen, K. T.; Punniyamurthy, T. Angew. Chem., Int. Ed.
2007, 46, 5583–5586; (m) Zhu, D.; Xu, L.; Wu, F.; Wan, B. Tetrahedron Lett.
2006, 47, 5781–5784; (n) Chen, Y.-J.; Chen, H.-H. Org. Lett. 2006, 8, 5609–5612;
(o) Deng, W.; Zou, Y.; Wang, Y-. F.; Liu, L.; Guo, Q.-X. Synlett 2004, 1254–1258;
(p) Kwong, Y. F.; Buchwald, L. S. Org. Lett. 2002, 4, 3517–3520; (q) Bates, G. C.;
Gujadhur, K. R.; Venkataraman, D. Org. Lett. 2002, 4, 2803–2806.
5. Correa, A.; Carril, M.; Bolm, C. Angew. Chem., Int. Ed. 2008, 47, 2880–2883.
6. Wong, Y.-C.; Jayanth, T. T.; Cheng, C.-H. Org. Lett. 2006, 8, 5613–5616.
7. (a) Mispelaere-Canivet, C.; Spindler, J.-F.; Perrio, S.; Beslin, P. Tetrahedron 2005,
61, 5253–5259; (b) Itoh, T.; Mase, T. Org. Lett. 2004, 6, 4587–4590; (c) Zheng,
N.; McWilliams, J. C.; Fleitz, F. J.; Armstrong, J. D., III; Volante, R. P. J. Org. Chem.
1998, 63, 9606–9607.
8. (a) Savarin, C.; Srogl, J.; Liebeskind, L. S. Org. Lett. 2002, 4, 4309–4312; (b)
Herradura, P. S.; Pendola, K. A.; Guy, R. K. Org. Lett. 2000, 2, 2019–2022.
9. (a) Gómez-Benítez, V.; Baldovino-Pantaleón, O.; Herrera-Álvarez, C.; Toscano,
R. A.; Morales-Morales, D. Tetrahedron Lett. 2006, 47, 5059–5062; (b)
Fukuzawa, S.; Tanihara, D.; Kikuchi, S. Synlett 2006, 2145–2147; (c) Kumar,
S.; Engman, L. J. Org. Chem. 2006, 71, 5400–5403; (d) Tanigichi, N. J. Org. Chem.
2004, 69, 6904–6906; (e) Taniguchi, N.; Onami, T. J. Org. Chem. 2004, 69, 915–
920; (f) Baldovino-Pantaleón, O.; Hernández-Ortega, S.; Morales-Morales, D.
Inorg. Chem. Commun. 2005, 8, 955–959; (g) Baldovino-Pantaleón, O.;
Hernández-Ortega, S.; Morales-Morales, D. Adv. Synth. Catal. 2006, 348, 236–
242.
Compound 3ad: Colorless oil. 1H NMR (CDCl3, 300 MHz) d 2.48 (s, 3H), 7.20–
7.41(m, 6H), 7.56–7.60 (m, 1H), 7.70 (d, 1H, J = 7.6 Hz); 13C NMR (CDCl3) d 20.9
(CH3), 110.0 (CH), 118.9 (CH), 124.0 (CH), 124.2 (CH), 126.2 (C), 127.0 (CH),
130.6 (CH), 131.1 (CH), 136.1 (CH), 142.0 (C), 142.5 (C), 151.8 (C), 163.2 (C). ESI
HRMS calcd for C14H11NOS [M + H] 242.0640, found 242.0642. EI MS m/z = 241.
Compound 3ae: Colorless oil. 1H NMR (CDCl3, 300 MHz) d 7.18–7.30 (m, 2H),
7.35–7.46 (m, 1H), 7.42 (d, 2H, J = 8.8 Hz), 7.56-7.60 (m, 1H), 7.63 (d, 2H,
J = 8.8 Hz); 13C NMR (CDCl3) d 110.0 (CH), 119.1 (CH), 124.4 (CH), 124.4 (CH),
125.5 (C), 129.9 (CH), 135.7 (CH), 136.4 (CH), 141.8 (C), 151.8 (C), 162.7 (C). ESI
HRMS calcd for C13H8NOSCl [M + H] 262.0093, found 262.0099. EI MS m/
z = 261, 263.
Compound 3ah: White solid. Mp = 79–81 °C. 1H NMR (CDCl3, 300 MHz) d 7.21–
7.26 (m, 2H), 7.38–7.41 (m, 1H), 7.52–7.61 (m, 3H), 7.69–7.72 (m, 1H), 7.84–
7.93 (m, 3H), 8.23 (s, 1H); 13C NMR (CDCl3) d 110.0 (CH), 119.1 (CH), 124.2 (C),
124.3 (CH), 124.4 (CH), 126.9 (CH), 127.5 (CH), 127.8 (CH), 128.0 (CH), 129.4
(CH), 130.7 (CH), 133.5 (C), 133.6 (C), 134.3 (CH), 142.0 (C), 151.9 (C), 163.3 (C).
ESI HRMS calcd for C17H11NOS [M + H] 278.0640, found 278.0492. EI MS m/
z = 277.
Compound 3ba: Colorless oil. 1H NMR (CDCl3, 300 MHz) d 2.42 (s, 3H), 7.05 (d,
J = 8.2 Hz, 1H), 7.26–7.99 (m, 1H), 7.39–7.47 (m, 4H), 7.67–7.71 (m, 2H); 13C
NMR (CDCl3) d 21.4 (CH3), 109.4 (CH), 119.1 (CH), 125.3 (CH), 127.3 (C), 129.6
(CH) , 129.7 (CH), 134.2 (CH), 134.2 (C), 142.1 (C), 150.1 (C), 163.0 (C). ESI
HRMS calcd for C14H11NOS [M + H] 242.0640, found 242.0612. EI MS m/z = 241.
Compound 3ca: White Solid. Mp = 73–75 °C. 1H NMR (CDCl3, 300 MHz) d 7.19–
7.20 (m, 1H), 7.22 (d, 1H, J = 8.2 Hz), 7.45–7.50 (m, 3H), 7.56–7.58 (m, 1H),
7.69–7.72 (m, 2H); 13C NMR (CDCl3) d 110.6 (CH), 119.0 (CH), 124.4 (CH), 126.5
(C), 129.7 (CH), 129.9 (C), 130.1 (CH), 134.6 (CH), 143.1 (C), 150.4 (C), 165.2 (C).
ESI HRMS calcd for C13H8NOSCl [M + H] 262.0093, found 262.0076. EI MS m/
z = 261, 263.
13. 1,10-Phenanthroline and TMEDA were not effective as ligands.
14. The reaction in air gave the unsatisfactory yield of the product.
15. Taniguchi, N. Synlett 2006, 1351–1354.
16. In the reaction using CuBr2 as a catalyst, Cu(II) can be reduced Cu(I) species by
thiol: thiol is oxidized to disulfide. Higashi, L. S.; Lundeen, M.; Hilti, E.; Seff, K.
Inorg. Chem. 1977, 16, 310–313.
10. For reviews: (a) Alberico, D.; Scott, M. E.; Lautens, M. Chem. Rev. 2007, 107,
174–238; (b) Seregin, I. V.; Gevorgyan, V. Chem. Soc. Rev. 2007, 36, 1173–1193;
(c) Satoh, T.; Miura, M. Chem. Lett. 2007, 36, 200–205.
11. (a) Murru, S., Patal, B. K., Bras, J. L., Muzart, J., J. Org. Chem., ASAP.; (b) Berger, M.
D.; Dutia, M.; Powell, D.; Floyd, B. M.; Torres, N.; Mallon, R.; Wojciechowicz, D.;
Kim, S.; Feldberg, L.; Collins, K.; Chaudhary, I. Bioorg. Med. Chem. 2008, 16,